Myricx Bio
Pre-clinicalWe are a biotech company, headquartered in London, focused on discovering and developing a completely novel class of payloads for antibody drug conjugates (ADCs), based on inhibitors of the enzymes, N-myristoyltransferases (NMT) for the treatment of cancer.
Founded
2020
Focus
AntibodiesBiologicsSmall Molecules
About
We are a biotech company, headquartered in London, focused on discovering and developing a completely novel class of payloads for antibody drug conjugates (ADCs), based on inhibitors of the enzymes, N-myristoyltransferases (NMT) for the treatment of cancer.
Funding History
2Total raised: $93.7M
Series A$90MNovo HoldingsOct 15, 2023
Seed$3.7MNovartis Venture FundOct 15, 2021
Company Info
TypePrivate
Founded2020
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile